Therefore, Tang et al. showcase a novel pathway for treatment of COPD fibrosis, outlining a new regulatory axis in which PM2.5 disinhibits Osgin1 expression by blocking the actions of miR-654–5p, resulting in dysregulated autophagy and increased fibrosis. The gene discussed is OSGIN1; the disease is chronic obstructive pulmonary disease.